14.96
Usana Health Sciences Inc stock is traded at $14.96, with a volume of 224.66K.
It is up +3.67% in the last 24 hours and down -34.33% over the past month.
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
See More
Previous Close:
$14.43
Open:
$14.39
24h Volume:
224.66K
Relative Volume:
1.54
Market Cap:
$276.41M
Revenue:
$925.94M
Net Income/Loss:
$9.15M
P/E Ratio:
31.46
EPS:
0.4755
Net Cash Flow:
$2.96M
1W Performance:
+6.55%
1M Performance:
-34.33%
6M Performance:
-22.61%
1Y Performance:
-52.91%
Usana Health Sciences Inc Stock (USNA) Company Profile
Name
Usana Health Sciences Inc
Sector
Industry
Phone
(801) 954-7100
Address
3838 WEST PARKWAY BLVD., SALT LAKE CITY, UT
Compare USNA vs JBS, KHC, GIS, MKC, SJM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
USNA
Usana Health Sciences Inc
|
14.96 | 243.52M | 925.94M | 9.15M | 2.96M | 0.4755 |
|
JBS
Jbs Nv
|
13.03 | 44.57B | 88.25B | 1.91B | -681.64M | 1.6761 |
|
KHC
Kraft Heinz Co
|
24.85 | 30.32B | 24.99B | -5.76B | 3.95B | -4.863 |
|
GIS
General Mills Inc
|
38.29 | 21.18B | 18.42B | -85.30M | 1.63B | -0.1894 |
|
MKC
Mccormick Co Inc
|
52.08 | 14.85B | 7.39B | 1.63B | 1.02B | 6.0085 |
|
SJM
J M Smucker Co
|
126.08 | 13.15B | 9.05B | -138.70M | 1.16B | -1.307 |
Usana Health Sciences Inc Stock (USNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-23-23 | Initiated | Sidoti | Buy |
| Jul-07-22 | Downgrade | Jefferies | Hold → Underperform |
| Apr-14-22 | Initiated | DA Davidson | Neutral |
| Dec-17-20 | Initiated | ROTH Capital | Buy |
| Aug-22-19 | Initiated | Jefferies | Hold |
| Apr-16-19 | Initiated | Tigress Financial | Buy |
| Oct-25-18 | Upgrade | Sidoti | Neutral → Buy |
| Oct-24-18 | Upgrade | Pivotal Research Group | Hold → Buy |
| Apr-23-18 | Downgrade | Pivotal Research Group | Buy → Hold |
| Feb-07-18 | Reiterated | Pivotal Research Group | Buy |
| Jan-24-18 | Downgrade | Sidoti | Buy → Neutral |
| Oct-25-17 | Reiterated | Pivotal Research Group | Buy |
| Jul-26-17 | Reiterated | Pivotal Research Group | Buy |
| May-03-17 | Upgrade | Pivotal Research Group | Hold → Buy |
| May-01-17 | Downgrade | Pivotal Research Group | Buy → Hold |
| Feb-08-17 | Reiterated | Pivotal Research Group | Buy |
| Jul-28-16 | Reiterated | DA Davidson | Neutral |
| Feb-10-16 | Downgrade | DA Davidson | Buy → Neutral |
| Oct-16-15 | Upgrade | Sidoti | Neutral → Buy |
| Sep-16-15 | Upgrade | DA Davidson | Neutral → Buy |
| Aug-06-15 | Downgrade | DA Davidson | Buy → Neutral |
| Aug-05-15 | Upgrade | Pivotal Research Group | Hold → Buy |
| Jun-26-15 | Initiated | DA Davidson | Buy |
View All
Usana Health Sciences Inc Stock (USNA) Latest News
ETFs Investing in USANA Health Sciences, Inc. Stocks - TradingView
USANA (USNA) Quarterly Update: The Bottom-Line Figure Trails Its Comparison under the Current Snapshot; Price Action: The Market Price Moves 2.72% Higher in the Current UpdatePost-Earnings Drift - vinanet.vn
1,205,587 Shares in USANA Health Sciences, Inc. $USNA Bought by Pzena Investment Management LLC - MarketBeat
USANA Introduces 3-in-1 Protein, Creatine, and Electrolyte Drink Mix - GuruFocus
USANA launches Clear Protein + Creatine Mix wit... - Pluang
Top USANA Health Sciences (USNA) Competitors 2026 - MarketBeat
USANA Health Sciences (USNA) sees Renaissance report 5.19% equity stake - Stock Titan
USANA Health Sciences 2Q 2026: Revenue $223.3M, Net loss $(21.4)M, EPS $(1.16) — 10-Q Summary - TradingView
Usana Health Sciences | 10-Q: Q2 2026 Earnings Report - Moomoo
USANA Health Sciences (USNA) swings to Q2 loss after $29.1M Hiya impairment - Stock Titan
5 Must-Read Analyst Questions From USANA’s Q2 Earnings Call - Yahoo Finance
USANA Health Sciences (USNA) Drops 7.3% to $14.34: Critical Support at $13.62 in FocusTick Index - dars.gov.et
Sidoti Raises Earnings Estimates for USANA Health Sciences - MarketBeat
Why Usana Health Sciences Stock Plummeted This Week - The Motley Fool
Why Usana Health Sciences Stock Plummeted This Week - The Motley Fool
USANA Health Sciences Q2 Earnings Call Highlights - marketbeat.com
USANA Health Sciences (NYSE:USNA) Rating Lowered to Strong Sell at Zacks Research - MarketBeat
USANA Health Sciences (NYSE:USNA) Cut to "Hold" at Wall Street Zen - MarketBeat
Sidoti Brokers Decrease Earnings Estimates for USNA - MarketBeat
USANA Health Sciences, Inc. Just Missed Earnings With A Surprise LossHere Are Analysts Latest Forecasts - Moomoo
Should USANA Health Sciences (USNA) Revisit Its Valuation After Lowered Guidance And Q2 Loss? - Yahoo Finance
Usana Health Sciences Inc (USNA) (Q2 2026) Earnings Call Highlights: Strategic Pivots Amidst ... - Yahoo Finance
USANA Health Sciences: No Clear Growth Engine Left (Rating Downgrade) (NYSE:USNA) - Seeking Alpha
Earnings call transcript: USANA Health Sciences posts Q2 2026 loss, stock sinks 28% - Investing.com Canada
USANA Reports Q2 2026 Financial Results - Direct Selling News
Why USANA (USNA) Stock Is Nosediving - TradingView
USANA Chairman, CEO Kevin Guest Shares 5 Ways to Make Happiness Happen at Work and Home This August - Morningstar
Why is USANA Health Sciences stock collapsing today? - Investing.com
Why is USANA Health Sciences stock collapsing today? By Investing.com - Investing.com Canada
USANA CEO urges embracing small moments of happ... - Pluang
USANA CEO's Parents Bought a Piano Before a Car—They Still Own It - Stock Titan
USANA Health: Q2 Earnings Snapshot - theheraldreview.com
Lazard Asset Management LLC Invests $1.26 Million in USANA Health Sciences, Inc. $USNA - MarketBeat
USANA Health Sciences (NYSE:USNA) Shares Tumble as Q2 Results Miss and Guidance Slashed - ChartMill
USANA Health Sciences (NYSE:USNA) Releases FY 2026 Earnings Guidance - MarketBeat
USANA Health Sciences (USNA) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
USANA (NYSE:USNA) Misses Q2 CY2026 Sales Expectations, Stock Drops 19.2% - Yahoo Finance
USANA Health Sciences (NYSE:USNA) Posts Earnings Results, Misses Estimates By $0.50 EPS - MarketBeat
USANA Reports $223.3 Million Q2 Net Sales and $21.4 Million Loss - Quiver Quantitative
USANA Health Sciences (NYSE: USNA) swings to Q2 loss, trims 2026 forecast - Stock Titan
USANA Updates 2026 Sales Outlook After Hiya, Rise Fall Short - Stock Titan
USANA Health Sciences Q2 2026 Earnings Call Transcript - MarketBeat
Earnings To Watch: USANA (USNA) Reports Q2 Results Tomorrow - Yahoo Finance
USANA Health Sciences, Inc. Revenue Breakdown – NYSE:USNA - TradingView
USANA Health Sciences (USNA) Holds Near Key Support as Shares Trade at $22.11Retail Driven Moves - vinanet.vn
New 12-Week Consumer Study Highlights Visible Skin Benefits with USANA Glow - Nasdaq
Glow-Promoting Cellular Nutrition Formulas: USANA Health Sciences Shares the Benefits… - Trend Hunter
USANA Health Sciences Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
How Usana Health Sciences Inc. (USNA) Affects Rotational Strategy Timing - Stock Traders Daily
USANA Health Sciences (USNA) to Announce Earnings on Tuesday - MarketBeat
USANA Health Sciences Inc (USNA) Cash Flow - TradingKey
Usana Health Sciences Inc Stock (USNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):